Ebos profit soars in first full year of Symbion, sees growth in 2015

Ebos profit soars in first full year of Symbion, sees growth in 2015
By Suze Metherell Aug. 26 (BusinessDesk) - Ebos Group, the healthcare and animal care manufacturer, posted full-year profit that almost tripled on a full 12-month contribution from the Symbion pharmaceutical wholesaler and distributor in Australia. Net profit was $92.1 million, or 62.8 cents a share, in the year ended June 30, from  $28.2 million, or 46.8 cents, a year earlier, the Christchurch-based company said in a statement. Sales jumped 216 percent to $5.76 billion.  The $1.1 billion cash and scrip Symbion purchase in June 2013 wa...